Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 27, 2011
Sorafenib and sunitinib, two anticancer drugs, inhibit CYP3A4-mediated and activate CY3A5-mediated midazolam 1'-hydroxylationMinako Sugiyama, Ken-ichi Fujita, Norie Murayama, et al.
Cancer Chemotherapy and Pharmacology|November 26, 2011
Pharmacokinetic analysis of capecitabine and cisplatin in combination with trastuzumab in Japanese patients with advanced HER2-positive gastric cancerTaroh Satoh, Yasushi Omuro, Yasutsuna Sasaki, et al.
Cancer Chemotherapy and Pharmacology|June 22, 2010
Pharmacokinetic analysis of carboplatin in patients with cancer who are undergoing hemodialysisTomoyo Oguri, Tomoya Shimokata, Megumi Inada, et al.
Cancer Science|March 18, 2006
Pharmacokinetics and pharmacodynamics of protein-unbound docetaxel in cancer patientsHironobu Minami, Kenji Kawada, Yasutsuna Sasaki, et al.
International Journal of Cancer|June 1, 2006
Simple combinations of 5-FU pathway genes predict the outcome of metastatic gastric cancer patients treated by S-1Wataru Ichikawa, Takehiro Takahashi, Kenichi Suto, et al.
International Journal of Cancer|August 19, 2004
Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in relation to differentiation of gastric cancerWataru Ichikawa, Takehiro Takahashi, Kenichi Suto, et al.
International Journal of Clinical Oncology|September 27, 2012
A phase II study of lapatinib for brain metastases in patients with HER2-overexpressing breast cancer following trastuzumab based systemic therapy and cranial radiotherapy: subset analysis of Japanese patientsHiroji Iwata, Masaru Narabayashi, Yoshinori Ito, et al.
Cancer Chemotherapy and Pharmacology|July 24, 2014
No pharmacokinetic alteration of docetaxel following coadministration of aprepitant 3 h before docetaxel infusionToshikado Kaneta, Ken-Ichi Fujita, Yuko Akiyama, et al.
BMC Pulmonary Medicine|November 30, 2022
Pharmacokinetics of gefitinib in elderly patients with EGFR-mutated advanced non-small cell lung cancer: a prospective studyYuta Nio, Hiroo Ishida, Natsumi Matsumoto, et al.
Journal of Pharmaceutical Sciences|May 9, 2017
Involvement of the Transporters P-Glycoprotein and Breast Cancer Resistance Protein in Dermal Distribution of the Multikinase Inhibitor Regorafenib and Its Active MetabolitesKen-Ichi Fujita, Yusuke Masuo, Erina Yamazaki, et al.
Pageof 11